The Effect of Grape Seed Extract on Blood Pressure in People With Pre-Hypertension



Status:Active, not recruiting
Conditions:High Blood Pressure (Hypertension)
Therapuetic Areas:Cardiology / Vascular Diseases
Healthy:No
Age Range:25 - 65
Updated:4/17/2018
Start Date:November 15, 2009
End Date:October 15, 2019

Use our guide to learn which trials are right for you!

Randomized, Double-blind, Placebo-controlled Trial to Investigate the Effect of Grape Seed Extract Delivered in a Beverage on Blood Pressure in Individuals With Pre-hypertension.

In this research study, the investigators are interested in learning how extracts from grape
seeds can help those individuals with high blood pressure. The investigators also hope to
learn how grape seed extract effects your blood and cell functions.

The grape seed extract the investigators will use in the study will be provided either in a
beverage or a capsule form and is currently available on the market. This study is also using
a placebo; therefore the treatment subjects receive may or may not contain the grape seed
extract.

The purpose of this study is to determine if the grape seed extract (GSE) will lower blood
pressure in people with slightly high blood pressure (Pre-Hypertension).

Elevated blood pressure, or hypertension, is a major risk factor for heart disease and
stroke. Systolic and diastolic blood pressures meeting criteria for "pre-hypertension" double
the absolute risk of stroke and ischemic heart disease over an extended age range from the
4th to the 8th decade of life. Lifestyle, particularly the diet, is critical in the
prevention and management of hypertension. Polyphenolic compounds from various plant foods
can promote blood pressure regulation and vascular health through protection of the
endothelium from oxidant and or inflammatory stress and or stimulation of smooth muscle
relaxation.

We will use a purified grape seed extract (GSE) in the proposed trial. This extract has been
granted Generally Recognized as Safe (GRAS) status by Food and drug administration (GRAS
Notice # GRN 000125, dated 08/18/2003, FDA, USA). Furthermore, GSE for use in the present
trial has been used in previous human clinical trails and shown potent vasodilator properties
in vitro and blood pressure lowering in metabolic syndrome patients. The proposed trial aims
to verify the blood pressure lowering effect of GSE in an 'at risk' population for
hypertension and to explore the extent to which other pathways of chronic disease may be
modulated by GSE consumption.

Given this, the objectives of this study are as follows:

1. The primary objective of the proposed study is to demonstrate the effectiveness of GSE
to lower blood pressure in pre-hypertensive individuals.

2. Secondary objectives will investigate the role of GSE to improve inflammatory- and
oxidative stress- status, as well as its effect on endothelium function.

Inclusion Criteria:

- male and female

- pre-hypertensive

- systolic blood pressure (mmHg) 120 - 139 or

- diastolic blood pressure (mmHg) 80 -89

- no clinical evidence of cardiovascular, respiratory, renal, gastrointestinal or
hepatic disease

Exclusion Criteria:

- pregnant and or lactating

- taking over the counter antioxidant supplements

- taking prescription medications that may interfere with study procedures or endpoints

- unusual dietary habits

- actively trying to lose or gain weight

- addicted to drugs and/or alcohol

- medically documented psychiatric or neurological disturbances

- smoker (past smoker may be allowed if cessation is > 2 years)
We found this trial at
1
site
Chicago, Illinois 60616
?
mi
from
Chicago, IL
Click here to add this to my saved trials